3 completed, 1 recruiting. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow GPN Vaccines: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Serum Collection Study for Assay Development Gamma-PN - Pneumococcal Disease, Invasive, Pneumococcal Disease | Phase 1 | Recruiting | GPN Vaccines | 12 | 2025-10-01 | 2025-10-03 |
| Study of Gamma PN3 in the Elderly Gamma PN3, Prevnar - Pneumonia, Pneumococcal | Phase 1 | Completed | GPN Vaccines | 105 | 2024-08-26 | 2025-05-11 |
| Extension Safety and Immunogenicity Study of GPNV-001 Gamma-PN3, Pneumovax-23, Prevenar-13 - Pneumococcal Infections | Phase 1 / Phase 2 | Completed | GPN Vaccines | 60 | 2023-07-17 | 2024-12-18 |
| Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3. Gamma-PN3, Prevenar-13, Pneumovax-23 - Pneumococcal Infections | Phase 1 | Completed | GPN Vaccines | 118 | 2023-01-16 | 2024-09-05 |
Pneumococcal Infections (3) · Pneumonia, Pneumococcal (1)
13-valent pneumococcal vaccine (2) · Heptavalent Pneumococcal Conjugate Vaccine (1)
Australia (4)
Eve Kennedy, PhD (1) · Sepehr Shakib, MD (1)